Occurrence of lymphoplasmacytic lymphoma in a chronic myeloid leukemia patient following long-term treatment with tyrosine kinase inhibitors: A case report

INTRODUCTION: After tyrosine kinase inhibitors (TKIs) targeting BCR-ABL1 were introduced for the treatment of chronic myeloid leukemia, clinical outcomes have improved dramatically. However, together with the increase in the survival rate, a more frequent occurrence of secondary malignancies has bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Chang-Hoon, Jeon, So Yeon, Yhim, Ho-Young, Jang, Kyu Yun, Kwak, Jae-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220158/
https://www.ncbi.nlm.nih.gov/pubmed/32384445
http://dx.doi.org/10.1097/MD.0000000000019962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220158/
https://www.ncbi.nlm.nih.gov/pubmed/32384445
http://dx.doi.org/10.1097/MD.0000000000019962

Ejemplares similares